| Financial Year |
March 31 2023 |
| Monetary Funds |
486,763,105.43 |
| Held-for-trading Financial Assets |
2,039,261.41 |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
585,062,569.70 |
| Advances to Suppliers |
3,934,506.63 |
| Other Receivables |
13,282,826.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,133,754.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,383,504.38 |
| Other Current Assets |
24,249,998.20 |
| Total Current Assets |
1,398,498,927.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,835,048.52 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
238,772,945.18 |
| Under-construction Projects |
9,487,655.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,491,428.04 |
| R&D expenses |
-- |
| Goodwill |
17,263,279.11 |
| Long-Term Deferred and Prepaid Expenses |
24,094,717.95 |
| Deferred Income Tax Assets |
53,877,137.32 |
| Other Non-Current Assets |
14,647,413.02 |
| Sub-Total of Non-Current Assets |
456,396,484.23 |
| Total Assets |
1,854,895,411.32 |
| Short-Term Loans |
1,616,402.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
85,877,910.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,586,768.59 |
| Taxes Payable |
67,845,201.12 |
| Interest Payable |
-- |
| Dividend Payable |
46,550.00 |
| Other payables |
2,482,183.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,382,429.25 |
| Other Current Liabilities |
22,936,874.00 |
| Sub-Total of Current Liabilities |
191,110,024.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,032,670.34 |
| Deferred Income Tax Liabilities |
5,113,611.96 |
| Other Non-Current Liabilities |
16,000,000.00 |
| Sub-Total of Non-Current Liabilities |
65,233,021.08 |
| Total Liabilities |
256,343,045.11 |
| Paid-In Capital(Or Share Stock) |
113,247,072.00 |
| Capital Surplus |
1,231,082,064.08 |
| Surplus Reserve |
42,547,425.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
210,883,097.24 |
| Minority Stockholder's Interest |
792,707.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,597,759,658.40 |
| Owner's Equity（Stockholder's Equity） |
1,598,552,366.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,854,895,411.32 |
